ROCK2 Promotes Osteosarcoma Growth and Glycolysis by Up-Regulating HKII via Phospho-PI3K/AKT Signalling

References

• Matsuda K, Miyoshi H, Hiraoka K, et al. Elevated expression of transforming acidic coiled-coil containing protein 3 (TACC3) is associated with a poor prognosis in osteosarcoma. Clin Orthop Relat Res. 2018;476(9):1848–1855. doi:10.1097/CORR.000000000000037930024460
   PubMed Web of Science ®Google Scholar
• Lu Y, Wang Q, Zhou Y, et al. Overexpression of p62 is associated with poor prognosis and aggressive phenotypes in osteosarcoma. Oncol Lett. 2018;15(6):9889–9895. doi:10.3892/ol.2018.857929928361
   PubMed Web of Science ®Google Scholar
• Dekkers IA, Cleven A, Lamb HJ, Kroon HM. Primary osteosarcoma of the breast. Radiographics. 2019;39(3):626–629. doi:10.1148/rg.201918018131059400
   PubMed Web of Science ®Google Scholar
• Li Y, Ye T, Gu Q, Dong L, Chen G, Lu S. Primary, cardiac, fibroblastic osteosarcoma: a case report. Medicine (Baltimore). 2018;97(1):e9543. doi:10.1097/MD.000000000000954329505531
   PubMed Web of Science ®Google Scholar
• Turner H, Seguin B, Worley DR, et al. Prognosis for dogs with stage III osteosarcoma following treatment with amputation and chemotherapy with and without metastasectomy. J Am Vet Med Assoc. 2017;251(11):1293–1305. doi:10.2460/javma.251.11.129329154712
   PubMed Web of Science ®Google Scholar
• Yu D, Zhang S, Feng A, et al. Methotrexate, doxorubicin, and cisplatinum regimen is still the preferred option for osteosarcoma chemotherapy: a meta-analysis and clinical observation. Medicine (Baltimore). 2019;98(19):e15582. doi:10.1097/MD.000000000001558231083238
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhao H, Xu W, Jiang D, Huang L, Li L. High expression of PQBP1 and low expression of PCK2 are associated with metastasis and recurrence of osteosarcoma and unfavorable survival outcomes of the patients. J Cancer. 2019;10(9):2091–2101. doi:10.7150/jca.2848031205570
   PubMed Web of Science ®Google Scholar
• Zaim M, Isik S. DNA topoisomerase iIbeta stimulates neurite outgrowth in neural differentiated human mesenchymal stem cells through regulation of Rho-GTPases (RhoA/Rock2 pathway) and nurr1 expression. Stem Cell Res Ther. 2018;9(1):114. doi:10.1186/s13287-018-0859-429695291
   PubMed Web of Science ®Google Scholar
• Qiu Y, Yuan R, Zhang S, et al. Rock2 stabilizes beta-catenin to promote tumor invasion and metastasis in colorectal cancer. Biochem Biophys Res Commun. 2015;467(4):629–637. doi:10.1016/j.bbrc.2015.10.10326505794
   PubMed Web of Science ®Google Scholar
• Loirand G, Touyz RM. Rho kinases in health and disease: from basic science to translational research. Pharmacol Rev. 2015;67(4):1074–1095. doi:10.1124/pr.115.01059526419448
   PubMed Web of Science ®Google Scholar
• Hu K, Wang Z, Tao Y. [Suppression of hepatocellular carcinoma invasion and metastasis by Rho-kinase inhibitor Fasudil through inhibition of BTBD7-ROCK2 signaling pathway]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014;39(12):1221–1227. Chinese. doi:10.11817/j.issn.1672-7347.2014.12.00125544168
   PubMedGoogle Scholar
• Wang HF, Takenaka K, Nakanishi A, Miki Y. BRCA2 and nucleophosmin coregulate centrosome amplification and form a complex with the Rho effector kinase ROCK2. Cancer Res. 2011;71(1):68–77. doi:10.1158/0008-5472.CAN-10-003021084279
   PubMed Web of Science ®Google Scholar
• Kroiss A, Vincent S, Decaussin-Petrucci M, et al. Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2. Oncogene. 2015;34(22):2846–2855. doi:10.1038/onc.2014.22225065599
   PubMed Web of Science ®Google Scholar
• Vigil D, Kim TY, Plachco A, et al. ROCK1 and ROCK2 are required for non-small cell lung cancer anchorage-independent growth and invasion. Cancer Res. 2012;72(20):5338–5347. doi:10.1158/0008-5472.CAN-11-237322942252
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu X, Zhou W, et al. Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2. Cell Death Dis. 2018;9(2):190. doi:10.1038/s41419-017-0251-929416017
   PubMed Web of Science ®Google Scholar
• Nagai Y, Matoba K, Kawanami D, et al. ROCK2 regulates TGF-beta-induced expression of CTGF and profibrotic genes via NF-kappaB and cytoskeleton dynamics in mesangial cells. Am J Physiol Renal Physiol. 2019;317(4):F839–F851. doi:10.1152/ajprenal.00596.201831364374
   PubMed Web of Science ®Google Scholar
• Soliman H, Nyamandi V, Garcia-Patino M, et al. ROCK2 promotes ryanodine receptor phosphorylation and arrhythmic calcium release in diabetic cardiomyocytes. Int J Cardiol. 2019;281:90–98. doi:10.1016/j.ijcard.2019.01.07530728103
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Banno K, Kunitomi H, et al. Warburg effect in gynecologic cancers. J Obstet Gynaecol Res. 2019;45(3):542–548. doi:10.1111/jog.1386730511455
   PubMed Web of Science ®Google Scholar
• Li H, Xu H, Xing R, et al. Pyruvate kinase M2 contributes to cell growth in gastric cancer via aerobic glycolysis. Pathol Res Pract. 2019;215(6):152409. doi:10.1016/j.prp.2019.04.00131000383
   PubMed Web of Science ®Google Scholar
• Lim SO, Li CW, Xia W, et al. EGFR signaling enhances aerobic glycolysis in triple-negative breast cancer cells to promote tumor growth and immune escape. Cancer Res. 2016;76(5):1284–1296. doi:10.1158/0008-5472.CAN-15-247826759242
   PubMed Web of Science ®Google Scholar
• Pavlides S, Vera I, Gandara R, et al. Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis. Antioxid Redox Signal. 2012;16(11):1264–1284. doi:10.1089/ars.2011.424321883043
   PubMed Web of Science ®Google Scholar
• Shen Y, Zhao S, Wang S, et al. S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma. EBioMedicine. 2019;40:210–223. doi:10.1016/j.ebiom.2018.12.03830587459
   PubMed Web of Science ®Google Scholar
• Xiao Q, Wei Z, Li Y, et al. miR186 functions as a tumor suppressor in osteosarcoma cells by suppressing the malignant phenotype and aerobic glycolysis. Oncol Rep. 2018;39(6):2703–2710. doi:10.3892/or.2018.639429693191
   PubMed Web of Science ®Google Scholar
• Zhao X, Lu C, Chu W, et al. MicroRNA-124 suppresses proliferation and glycolysis in non-small cell lung cancer cells by targeting AKT-GLUT1/HKII. Tumour Biol. 2017;39(5):1010428317706215. doi:10.1177/101042831770621528488541
   PubMedGoogle Scholar
• Liu C, Wang X, Zhang Y. The roles of HK2 on tumorigenesis of cervical cancer. Technol Cancer Res Treat. 2019;18:1533033819871306. doi:10.1177/153303381987130631530094
   PubMed Web of Science ®Google Scholar
• Liu CC, Chou KT, Hsu JW, et al. High metabolic rate and stem cell characteristics of esophageal cancer stem-like cells depend on the Hsp27-AKT-HK2 pathway. Int J Cancer. 2019;145(8):2144–2156. doi:10.1002/ijc.3230130920655
   PubMed Web of Science ®Google Scholar
• Jiang X, Zhang Z, Song C, et al. Glaucocalyxin A reverses EMT and TGF-beta1-induced EMT by inhibiting TGF-beta1/Smad2/3 signaling pathway in osteosarcoma. Chem Biol Interact. 2019;307:158–166. doi:10.1016/j.cbi.2019.05.00531059706
   PubMed Web of Science ®Google Scholar
• Chen W, Gong P, Guo J, et al. Glycolysis regulates pollen tube polarity via Rho GTPase signaling. PLoS Genet. 2018;14(4):e1007373. doi:10.1371/journal.pgen.100737329702701
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhu X, Wu H, et al. Targeting the ROS/PI3K/AKT/HIF-1alpha/HK2 axis of breast cancer cells: combined administration of polydatin and 2-Deoxy-d-glucose. J Cell Mol Med. 2019;23(5):3711–3723. doi:10.1111/jcmm.1427630920152
   PubMed Web of Science ®Google Scholar
• Deng X, Yi X, Deng J, et al. ROCK2 promotes osteosarcoma growth and metastasis by modifying PFKFB3 ubiquitination and degradation. Exp Cell Res. 2019;385(2):111689. doi:10.1016/j.yexcr.2019.11168931678169
   PubMed Web of Science ®Google Scholar
• Jiao L, Zhang HL, Li DD, et al. Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2). Autophagy. 2018;14(4):671–684. doi:10.1080/15548627.2017.138180428980855
   PubMed Web of Science ®Google Scholar
• Wang H, Peng R, Chen X, et al. Effect of HK2, PKM2 and LDHA on cetuximab efficacy in metastatic colorectal cancer. Oncol Lett. 2018;15(4):5553–5560. doi:10.3892/ol.2018.800529552193
   PubMed Web of Science ®Google Scholar
• Lu Z, Guo Y, Zhang X, et al. ORY-1001 suppresses cell growth and induces apoptosis in lung cancer through triggering HK2 mediated warburg effect. Front Pharmacol. 2018;9:1411. doi:10.3389/fphar.2018.0141130568590
   PubMed Web of Science ®Google Scholar
• Song W, Wang Z, Gu X, et al. TRIM11 promotes proliferation and glycolysis of breast cancer cells via targeting AKT/GLUT1 pathway. Onco Targets Ther. 2019;12:4975–4984. doi:10.2147/OTT.S20772331388304
   PubMed Web of Science ®Google Scholar
• Song K, Song J, Lin K, et al. Survival analysis of patients with metastatic osteosarcoma: a surveillance, epidemiology, and end results population-based study. Int Orthop. 2019;43(8):1983–1991. doi:10.1007/s00264-019-04348-431127366
   PubMed Web of Science ®Google Scholar
• Kalender ME, Demiryurek S, Oztuzcu S, et al. Association between the Thr431Asn polymorphism of the ROCK2 gene and risk of developing metastases of breast cancer. Oncol Res. 2009;18(11):583–591. doi:10.3727/096504010X12767359113767
   Web of Science ®Google Scholar
• Pranatharthi A, Thomas P, Udayashankar AH, et al. RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer. J Exp Clin Cancer Res. 2019;38(1):392. doi:10.1186/s13046-019-1385-731488179
   PubMed Web of Science ®Google Scholar